Bruker (BRKR) Long-Term Debt Issuances (2012 - 2025)
Bruker (BRKR) posted Long-Term Debt Issuances of $600000.0 for Q4 2025, down 79.31% on a QoQ basis from $2.9 million in Q1 2025, and down 50.0% year-over-year from $1.2 million in Q4 2024.
Bruker (BRKR) Long-Term Debt Issuances (2012 - 2025) Analysis & Trends
Bruker's Long-Term Debt Issuances history runs 12 years deep, the most recent figure standing at $600000.0 for Q4 2025.
- Quarterly Long-Term Debt Issuances fell 50.0% year-over-year to $600000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $600000.0 (down 99.94% YoY) and the FY2025 annual result came in at $3.5 million, down 99.64% from the prior year.
- Long-Term Debt Issuances was $600000.0 for Q4 2025 at Bruker, down from $2.9 million in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $805.7 million in Q2 2024 and bottomed at -$9.8 million in Q3 2023.
- A 5-year average of $86.5 million and a median of $600000.0 in 2025 frame the typical range for Long-Term Debt Issuances.
- Annual changes were most pronounced in 2021 — Long-Term Debt Issuances jumped 70428.57% — and 2023, when it plunged 4800.0%.
- Bruker's Long-Term Debt Issuances stood at $492.3 million in 2021, then slumped by 99.7% to $1.5 million in 2022, then surged by 500.0% to $9.0 million in 2023, then plunged by 86.67% to $1.2 million in 2024, then plunged by 50.0% to $600000.0 in 2025.
- Business Quant data shows BRKR's Long-Term Debt Issuances at $600000.0 in Q4 2025, $2.9 million in Q1 2025, and $1.2 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | 1.15 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 11.71 Mn |
| 10 | Bruker | 9.26 Bn | 9.26 Bn | 379.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Mar 31, 2025 | 2.90 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 166.80 Mn |
| Sep 30, 2024 | 166.80 Mn |
| Jun 30, 2024 | 805.70 Mn |
| Jun 30, 2024 | 805.70 Mn |
| Dec 31, 2023 | 9.00 Mn |
| Dec 31, 2023 | 9.00 Mn |
| Sep 30, 2023 | -9.80 Mn |
| Sep 30, 2023 | -9.80 Mn |
| Jun 30, 2023 | 4.90 Mn |
| Jun 30, 2023 | 4.90 Mn |
| Mar 31, 2023 | -2.10 Mn |
| Mar 31, 2023 | -2.10 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Dec 31, 2022 | 1.50 Mn |